Fiscal Year (FY) 2011 Funding Opportunity, 48173 [2011-19965]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 152 / Monday, August 8, 2011 / Notices
‘‘Small Molecule Activators of Pyruvate
Kinase,’’ filed April 8, 2011 [HHS Ref.
No. E–326–2008/0–US–07]; Australian
National Application No. 2009303335,
entitled ‘‘Small Molecule Activators of
Pyruvate Kinase,’’ filed October 9, 2010
[HHS Ref. No. E–326–2008/0–AU–03];
Canadian National Application, entitled
‘‘Small Molecule Activators of Pyruvate
Kinase,’’ filing date pending [HHS Ref.
No. E–326–2008/0–CA–04]; Japanese
National Application, entitled ‘‘Small
Molecule Activators of Pyruvate
Kinase,’’ filing date pending [HHS Ref.
No. E–326–2008/0–JP–06]; U.S.
Provisional Patent Application No. 61/
329,158, entitled ‘‘Pyruvate Kinase M2
Activators for the Treatment of Cancer,’’
filed April 29, 2010, now abandoned
[HHS Ref. No. E–120–2010/0–US–01];
and PCT Application PCT/US2011/
033852 entitled ‘‘Pyruvate Kinase M2
Activators for the Treatment of Cancer,’’
filed April 26, 2011 [HHS Ref. No. E–
120–2010/0–PCT–02] to Forma
Therapeutics, Inc., having an office at
790 Memorial Drive, Cambridge, MA
02139. The patent rights in these
inventions have been assigned to the
United States of America.
The prospective exclusive license
territory may be worldwide, and the
field of use may be limited to the use
of PKM2 activators as human
therapeutics for the treatment of cancer.
DATES: Only written comments and/or
applications for a license which are
received by the NIH Office of
Technology Transfer on or before
September 7, 2011 will be considered.
ADDRESSES: Requests for copies of the
patent application, inquiries, comments,
and other materials relating to the
contemplated exclusive license should
be directed to: Steven Standley, PhD,
Licensing and Patenting Manager, Office
of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville, MD
20852–3804; Telephone: (301) 435–
4074; Facsimile: (301) 402–0220; E-mail:
sstand@od.nih.gov.
SUPPLEMENTARY INFORMATION: The fetal
form of Pyruvate Kinase, called PKM2,
is expressed in all cancer cells and
imparts an important metabolic change
on cancer cells which allows them to
grow and divide rapidly. That is, PKM2
is normally inactive, which allows
cancer cells to create an abundance of
molecules for cellular growth and
division. The products and methods
sought in the prospective license
activate PKM2 and result in inhibition
of tumor development.
This invention relates to products and
methods of administering PKM2
activators of various types and methods
VerDate Mar<15>2010
18:57 Aug 05, 2011
Jkt 223001
of treating cancer and diseases
susceptible to PKM2 activators.
The prospective exclusive license will
be royalty bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless
within thirty (30) days from the date of
this published notice, the NIH receives
written evidence and argument that
establishes that the grant of the license
would not be consistent with the
requirements of 35 U.S.C. 209 and 37
CFR 404.7.
Applications for a license in the field
of use filed in response to this notice
will be treated as objections to the grant
of the contemplated exclusive license.
Comments and objections submitted to
this notice will not be made available
for public inspection and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
Dated: August 2, 2011.
Richard U. Rodriguez,
Director, Division of Technology Development
& Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2011–20003 Filed 8–5–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Fiscal Year (FY) 2011 Funding
Opportunity
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice of intent to award a
Single Source Grant to the Health
Service Center, Inc., Anniston, AL.
AGENCY:
This notice is to inform the
public that the Substance Abuse and
Mental Health Services Administration
(SAMHSA) intends to award
approximately $300,000 (total costs) per
year for up to four years to the Health
Service Center, Inc., Anniston, AL. This
is not a formal request for applications.
Assistance will be provided only to the
Health Service Center, Inc., Anniston,
AL, based on the receipt of a satisfactory
application that is approved by an
independent review group.
Funding Opportunity Title: SP–11–
005.
SUMMARY:
Catalog of Federal Domestic Assistance
(CFDA) Number: 93.243
apply. The Substance Abuse and Mental
Health Services Administration
(SAMHSA), Center for Substance Abuse
Prevention (CSAP) is seeking to award
a single source grant to the Health
Service Center, Inc., Anniston, AL, for
the Capacity Building Initiative (CBI).
CBI is one of CSAP’s Minority AIDS
Initiative (MAI) programs. The purpose
of the MAI is to provide substance abuse
and HIV prevention services to at-risk
minority populations in communities
disproportionately affected by HIV/
AIDS. The purpose of the CBI program
is to support an array of activities to
assist grantees in building a solid
foundation for delivering and sustaining
quality and accessible state of the
science substance abuse and HIV
prevention services. Specifically, the
program aims to engage colleges,
universities and community-level
domestic public and private non-profit
entities to prevent and reduce the onset
of SA and transmission of HIV/AIDS
among at-risk racial/ethnic minority
young adults, ages 18–24.
The Health Service Center, Inc.,
Anniston, AL, was funded under the
SP–10–004 CBI Initiative in FY 2010. At
that time, the Health Services Center,
Inc. proposed a 5-year program in their
grant application, but inadvertently
requested one year of funding rather
than the full program funding period of
5 years. It was clear from language in
the original application (which
specifically referred to individual years
of the program, and numbers served
throughout the project) that the grantee
intended to apply for funding for the
full five years. The purpose of this sole
source award is to fund the 4 out years
of the 5 year cooperative agreement
awarded under the initial
announcement. SAMHSA will not
accept an application from any other
entity.
FOR FURTHER INFORMATION CONTACT:
Shelly Hara, Substance Abuse and
Mental Health Services Administration,
1 Choke Cherry Road, Room 8–1095,
Rockville, MD 20857; telephone: (240)
276–2321; E-mail:
shelly.hara@samhsa.hhs.gov.
Cathy Friedman,
Public Health Analyst, SAMHSA .
[FR Doc. 2011–19965 Filed 8–5–11; 8:45 am]
BILLING CODE 4162–20–P
Authority: Section 516 of the Public
Health Service Act, as amended.
Justification: Only the Health Service
Center, Inc., Anniston, AL, is eligible to
PO 00000
Frm 00057
Fmt 4703
Sfmt 9990
48173
E:\FR\FM\08AUN1.SGM
08AUN1
]]>Agencies
[Federal Register Volume 76, Number 152 (Monday, August 8, 2011)]
[Notices]
[Page 48173]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-19965]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Fiscal Year (FY) 2011 Funding Opportunity
AGENCY: Substance Abuse and Mental Health Services Administration, HHS.
ACTION: Notice of intent to award a Single Source Grant to the Health
Service Center, Inc., Anniston, AL.
-----------------------------------------------------------------------
SUMMARY: This notice is to inform the public that the Substance Abuse
and Mental Health Services Administration (SAMHSA) intends to award
approximately $300,000 (total costs) per year for up to four years to
the Health Service Center, Inc., Anniston, AL. This is not a formal
request for applications. Assistance will be provided only to the
Health Service Center, Inc., Anniston, AL, based on the receipt of a
satisfactory application that is approved by an independent review
group.
Funding Opportunity Title: SP-11-005.
Catalog of Federal Domestic Assistance (CFDA) Number: 93.243
Authority: Section 516 of the Public Health Service Act, as
amended.
Justification: Only the Health Service Center, Inc., Anniston, AL,
is eligible to apply. The Substance Abuse and Mental Health Services
Administration (SAMHSA), Center for Substance Abuse Prevention (CSAP)
is seeking to award a single source grant to the Health Service Center,
Inc., Anniston, AL, for the Capacity Building Initiative (CBI). CBI is
one of CSAP's Minority AIDS Initiative (MAI) programs. The purpose of
the MAI is to provide substance abuse and HIV prevention services to
at-risk minority populations in communities disproportionately affected
by HIV/AIDS. The purpose of the CBI program is to support an array of
activities to assist grantees in building a solid foundation for
delivering and sustaining quality and accessible state of the science
substance abuse and HIV prevention services. Specifically, the program
aims to engage colleges, universities and community-level domestic
public and private non-profit entities to prevent and reduce the onset
of SA and transmission of HIV/AIDS among at-risk racial/ethnic minority
young adults, ages 18-24.
The Health Service Center, Inc., Anniston, AL, was funded under the
SP-10-004 CBI Initiative in FY 2010. At that time, the Health Services
Center, Inc. proposed a 5-year program in their grant application, but
inadvertently requested one year of funding rather than the full
program funding period of 5 years. It was clear from language in the
original application (which specifically referred to individual years
of the program, and numbers served throughout the project) that the
grantee intended to apply for funding for the full five years. The
purpose of this sole source award is to fund the 4 out years of the 5
year cooperative agreement awarded under the initial announcement.
SAMHSA will not accept an application from any other entity.
FOR FURTHER INFORMATION CONTACT: Shelly Hara, Substance Abuse and
Mental Health Services Administration, 1 Choke Cherry Road, Room 8-
1095, Rockville, MD 20857; telephone: (240) 276-2321; E-mail:
shelly.hara@samhsa.hhs.gov.
Cathy Friedman,
Public Health Analyst, SAMHSA .
[FR Doc. 2011-19965 Filed 8-5-11; 8:45 am]
BILLING CODE 4162-20-P
